| Antibiotics in agriculture and the risk to human health: how worried should we be? Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage Evolutionary applications 8 (3), 240-247, 2015 | 703 | 2015 |
| Meningococcal disease: changes in epidemiology and prevention Q Chang, YL Tzeng, DS Stephens Clinical epidemiology 4, 237-245, 2012 | 202 | 2012 |
| The participation of the Na+–Ca2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation JE Raizman, J Komljenovic, R Chang, C Deng, KM Bedosky, SG Rattan, ... Journal of cellular physiology 213 (2), 540-551, 2007 | 63 | 2007 |
| Microbial genomics of ancient plagues and outbreaks CP Andam, CJ Worby, Q Chang, MG Campana Trends in microbiology 24 (12), 978-990, 2016 | 59 | 2016 |
| Outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy after immuno-oncology checkpoint inhibitors J Graham, AY Shah, JC Wells, RR McKay, U Vaishampayan, A Hansen, ... European Urology Oncology 4 (1), 102-111, 2021 | 36 | 2021 |
| Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced Q Chang, AE Stevenson, NJ Croucher, GM Lee, SI Pelton, M Lipsitch, ... BMC infectious diseases 15, 1-7, 2015 | 35 | 2015 |
| Genomic epidemiology of penicillin-nonsusceptible pneumococci with nonvaccine serotypes causing invasive disease in the United States CP Andam, PK Mitchell, A Callendrello, Q Chang, J Corander, C Chaguza, ... Journal of clinical microbiology 55 (4), 1104-1115, 2017 | 27 | 2017 |
| Genomic epidemiology of meticillin-resistant Staphylococcus aureus ST22 widespread in communities of the Gaza Strip, 2009 Q Chang, I Abuelaish, A Biber, H Jaber, A Callendrello, CP Andam, ... Eurosurveillance 23 (34), 1700592, 2018 | 22 | 2018 |
| Real‐world assessment of clinical outcomes among first‐line sunitinib patients with clear cell metastatic renal cell carcinoma (mRCC) by the international mRCC database … MF Savard, JC Wells, J Graham, S Dudani, JA Steinharter, BA McGregor, ... The Oncologist 25 (5), 422-430, 2020 | 17 | 2020 |
| Missing data in marginal structural models: a plasmode simulation study comparing multiple imputation and inverse probability weighting SH Liu, SA Chrysanthopoulou, Q Chang, JN Hunnicutt, KL Lapane Medical care 57 (3), 237-243, 2019 | 16 | 2019 |
| Impact of host heterogeneity on the efficacy of interventions to reduce Staphylococcus aureus carriage Q Chang, M Lipsitch, WP Hanage infection control & hospital epidemiology 37 (2), 197-204, 2016 | 11 | 2016 |
| Determinants of meningococcal ACWY vaccination in adolescents in the US: completion and compliance with the CDC recommendations WY Cheng, R Chang, P Novy, C O’Connor, MS Duh, CS Hogea Human Vaccines & Immunotherapeutics 16 (1), 176-188, 2020 | 9 | 2020 |
| Real-world treatment patterns and clinical outcomes with Brentuximab vedotin or other standard therapies in patients with previously treated cutaneous T-Cell lymphoma in the … SK Barta, N Liu, M DerSarkissian, R Chang, M Ye, MS Duh, A Surinach, ... Clinical Lymphoma Myeloma and Leukemia 24 (2), e21-e32. e4, 2024 | 6 | 2024 |
| Veterans affairs prostate cancer treatment sequencing (VAPCaTS): a real-world evidence study of men with metastatic prostate cancer SJ Freedland, AM De Hoedt, M DerSarkissian, R Chang, A Satija, ... Urology Practice 8 (1), 112-118, 2021 | 3 | 2021 |
| Real-world clinical burden of sickle cell disease in the US community-practice setting: a single-center experience from the foundation for sickle cell disease research L Bronté-Hall, M Parkin, C Green, E Tchouambou, L Huynh, ... Blood 134, 5856, 2019 | 3 | 2019 |
| Characteristics, treatment patterns, and clinical outcomes of chronic hepatitis B across 3 continents: retrospective database study IA Gillespie, KA Chan, Y Liu, SF Hsieh, C Schindler, W Cheng, R Chang, ... Advances in Therapy 40 (2), 425-444, 2023 | 2 | 2023 |
| 1024. Real-world Adherence and Persistence with Long-Acting Cabotegravir Plus Rilpivirine (CAB+ RPV LA) Compared to Oral Antiretroviral Therapy (ART) Among People with HIV (PWH … C Garris, R Desai, R Chang, L Clear, Z Chen, D Liu, M DerSarkissian, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 055, 2023 | 1 | 2023 |
| Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs J Apple, M DerSarkissian, A Shah, R Chang, Y Chen, X He, J Chun Journal of Comparative Effectiveness Research 12 (11), e230107, 2023 | 1 | 2023 |
| Impact of Therapy Management on Axitinib-Related Adverse Events in Patients With Advanced Renal Cell Carcinoma Receiving First-Line Axitinib+ Checkpoint Inhibitor Y Zakharia, L Huynh, S Du, R Chang, S Pi, S Sundaresan, MS Duh, ... Clinical genitourinary cancer 21 (5), e343-e351, 2023 | 1 | 2023 |
| Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL) H Patel, SK Wahlstrom, M DerSarkissian, C Kunzweiler, F Castriota, ... Expert Review of Pharmacoeconomics & Outcomes Research 23 (6), 651-658, 2023 | 1 | 2023 |
